Cell Bridge Strategies

Founded in 2019, Cell Bridge Strategies is a specialized consulting firm operating at the intersection of advanced science and business strategy within the life sciences sector. The company leverages deep expertise in cell/gene therapy and regenerative medicine to offer services ranging from situational analysis and scientific strategy to biomanufacturing optimization and commercialization support. Led by founder and CEO Dr. Jane C. Andrews, the firm employs a flexible, expert-driven model to help clients navigate complex challenges from early-stage planning through to market expansion. Its core value proposition is bridging the gap between scientific innovation and commercial success in a fast-evolving global market.

Proprietary 'Top-Down & Bottom-Up' analytical models and Translational Analysis framework for aligning scientific innovation with business strategy and market demands.

Competes within the life sciences consulting segment against large global firms (e.g., McKinsey, IQVIA) with broader resources and numerous boutique specialists. Differentiation is achieved through a dedicated focus on cell/gene therapy and regenerative medicine, hands-on operational expertise, and a proprietary strategic analysis framework.